Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PSP-001 by Prosit Sole Biotechnology (Beijing) for Norovirus Infections: Likelihood of Approval
PSP-001 is under clinical development by Prosit Sole Biotechnology (Beijing) and currently in Phase I for Norovirus Infections. According to...